Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study.

Published on Jan 1, 2010in International Journal of Immunopathology and Pharmacology2.209
· DOI :10.1177/039463201002300128
Delia Colombo16
Estimated H-index: 16
,
A. Caputo2
Estimated H-index: 2
(University of Milan)
+ 4 AuthorsAlberto Giannetti54
Estimated H-index: 54
Sources
Abstract
Psychological distress (PD) is common in patients with psoriasis but little is known about its evolution. The aim of this study is to assess the evolution of PD in psoriasis. For this purpose, 1,505 psoriatic patients, who had been previously enrolled in the PSYCHAE study, an observational multicenter Italian study, were re-evaluated after 6 and 12 months. Minor and major PD were assessed using the General Health Questionnaire (GHQ) and Brief Symptoms Inventory (BSI) questionnaires and coping using Brief COPE questionnaire. Minor PD was present in 46% of patients but halved during the study. Female gender, surface area, topical steroids, methotrexate, self-distraction, venting and behavioral disengagement were risk factors for minor PD; cyclosporine and humor were protective. Major PD was present in 11% of patients and remained stable. Female gender, venting, religion, behavioral disengagement and emotional support were risk factors for major PD; instrumental support was protective. In conclusion, the res...
📖 Papers frequently viewed together
65 Citations
References29
Newest
#1Francesca SampognaH-Index: 35
#2Stefano TabolliH-Index: 27
Last. Damiano AbeniH-Index: 67
view all 6 authors...
Background/Aims: The management of psoriasis, which has a major impact on quality of life (QoL), deserves a specific attention to elderly patients’ problems and needs. Our aim was t
32 CitationsSource
#1Aldo F. Finzi (University of Milan)H-Index: 23
#2Delia Colombo (University of Milan)H-Index: 16
Last. Alberto GiannettiH-Index: 54
view all 9 authors...
Objective Our objectives were to determine the prevalence of psychological distress in a large sample of Italian patients with psoriasis; to establish whether disease severity and psychological distress are associated; to identify the strategies employed to cope with psoriasis; to evaluate the coping strategies employed by dermatologists; and to identify potential predictors of psychological distress. Design Cross-sectional. Setting Thirty-nine Italian dermatology centres. Subjects One thousand ...
65 CitationsSource
#1Alan Menter (Baylor University)H-Index: 29
#2Christopher E.M. Griffiths (University of Manchester)H-Index: 121
Summary Management of psoriasis begins with identification of the extent of cutaneous disease. However, a holistic, contractual approach to treatment is encouraged, with particular reference to psychosocial disability and quality-of-life issues. The presence of psoriasis on palms, soles, body folds, genitals, face, or nails, and concomitant joint disease, are also important when considering treatment options. An evidence-based approach is essential in delineating differences between the many ava...
245 CitationsSource
#1Kavita Vedhara (UoB: University of Bristol)H-Index: 30
#2Rona Moss Morris (University of Southampton)H-Index: 1
Last. Nicholas BirchallH-Index: 1
view all 6 authors...
Abstract Objective The present study examined the effects of emotional disclosure (ED) intervention on both disease severity and quality of life in patients with psoriasis. Methods Fifty-nine patients were recruited (mean age, 50 years; 32 men and 27 women; mean length of diagnosis, 22 years). Individuals were randomly assigned to receive ED intervention or standard control writing intervention. Disease severity, quality of life, and mood were assessed at baseline and at 2, 8, and 12 weeks posti...
32 CitationsSource
#1A.M. Eghlileb (Cardiff University)H-Index: 3
#2E. Davies (Cardiff University)H-Index: 1
Last. Andrew Yule Finlay (Cardiff University)H-Index: 80
view all 3 authors...
BACKGROUND: Psoriasis affects the quality of life (QoL) of relatives and partners of patients with psoriasis, but little is known about this secondary impact. OBJECTIVES: To identify the different ways in which the lives of relatives and partners of people with psoriasis are affected by the disease. METHODS: Relatives and partners of patients with psoriasis participated. Subjects were excluded if they had any skin disease. The severity of the psoriasis of the patients was measured using the Psor...
115 CitationsSource
#1Jochen Schmitt (TUD: Dresden University of Technology)H-Index: 65
#2Daniel E. Ford (Johns Hopkins University)H-Index: 81
Abstract Objectives The aim of this study was to assess associations between objective disease severity, psoriasis symptoms, illness-related stress (IRS), health-related quality of life (HRQL) and depressive symptoms in patients with psoriasis. Method Cross-sectional study conducted between January and May 2005. Recruitment of 265 adult patients with psoriasis through Internet advertisements. Analysis of the validity of different measurement models and the fit of hypothesized structural models u...
77 CitationsSource
Background Acceptance of an illness is regarded as a considerable problem in patients with chronic diseases. Lack of acceptance can lead to lower adherence to medical treatment and delayed clinical improvement. Psoriasis, being a chronic skin disease, is known to cause considerable distress to patients. Objectives To examine whether selected demographic factors and personal resources have an impact on acceptance of illness in psoriasis vulgaris patients. Methods Self-reported data on acceptance ...
37 CitationsSource
#1Christopher E.M. Griffiths (UBC: University of British Columbia)H-Index: 121
#2A. Katsambas (UBC: University of British Columbia)H-Index: 1
Last. K. Thestrup-Pedersen (UBC: University of British Columbia)H-Index: 1
view all 9 authors...
Summary Immune-mediated dermatoses, such as psoriasis and atopic dermatitis, affect a significant proportion of the population. Although most cases are not life threatening, these diseases can have a profound effect on the sufferer's quality of life and that of their family. Systemic therapy, such as ciclosporin, is often indicated for severe or recalcitrant disease. The efficacy of ciclosporin in the treatment of psoriasis and atopic dermatitis has been established and clinical data also demons...
51 CitationsSource
#1Silla M. ConsoliH-Index: 2
#2Sophie RolhionH-Index: 1
Last. Laurent MiseryH-Index: 60
view all 7 authors...
Background: Personality and emotional factors are thought to influence the onset of psoriasis, the occurrence of relapses, and the sensitivity of this condition to dermatological tr
55 CitationsSource
#1Dónal G. FortuneH-Index: 30
#2Helen L. Richards (University of Manchester)H-Index: 32
Last. Christopher E.M. Griffiths (University of Manchester)H-Index: 121
view all 6 authors...
Summary Background Psoriasis has a detrimental effect on patients' quality of life. However, there is a relative dearth of information on which aspects of a patient's well-being are affected by successful treatment. Objectives To investigate whether, and to what extent, improvement in the clinical severity of psoriasis induced by photochemotherapy with psoralen plus ultraviolet A (PUVA) translates into meaningful changes in beliefs about psoriasis, coping, stress, distress or disability. Methods...
65 CitationsSource
Cited By14
Newest
#1C.C. von Stülpnagel (UHH: University of Hamburg)H-Index: 1
#2Matthias Augustin (UHH: University of Hamburg)H-Index: 62
Last. Rachel Sommer (UHH: University of Hamburg)H-Index: 9
view all 5 authors...
Patients with chronic skin diseases suffer from physical and psychosocial impairments which can lead to a cumulative lifelong burden. Therefore, the concept of cumulative life course impairment (CLCI) was introduced, referring to the nonreversible damage due to the persistent life-long burden. This systematic review (PROSPERO registry number: CRD42020179141) aimed at mapping the risk factors and the associated burden over time in patients with psoriasis, atopic dermatitis (AD) and hidradenitis s...
Source
#1Maria Luigia Crosta (UCSC: Catholic University of the Sacred Heart)H-Index: 3
#2Clara De Simone (UCSC: Catholic University of the Sacred Heart)H-Index: 21
Last. Marco Di Nicola (UCSC: Catholic University of the Sacred Heart)H-Index: 31
view all 12 authors...
Abstract Aims Psoriasis is a chronic inflammatory skin disease with a complex etiology, involving the immune system, genetic factors, and external/internal triggers, with psychosomatic aspects. The aim of the study was to investigate childhood trauma and resilience in a psoriatic sample compared with healthy controls. Correlations between childhood trauma, resilience, quality of life, clinical data and psoriatic features were also evaluated. Methods Seventy-seven psoriatic patients and seventy-s...
11 CitationsSource
#1Chun-Ying WuH-Index: 55
#2Yun-Ting ChangH-Index: 30
Last. Yi-Ju ChenH-Index: 33
view all 8 authors...
Psoriasis patients with moderate to severe disease often present with depression and insomnia. Treatment targeting both psoriasis and psychological comorbidities is needed to improve the quality of life of these patients. In this nationwide cohort study, a total of 980 patients with psoriatic arthritis or psoriasis who had received nonbiological disease-modifying antirheumatic drugs and biologics therapy between 2009 and 2012 were identified. The prevalence rates of patients taking medications f...
32 CitationsSource
#1Delia Colombo (Novartis)H-Index: 16
#2Sergio ChimentiH-Index: 56
Last. Gilberto BelliaH-Index: 9
view all 9 authors...
Sex medicine studies have shown that there are sex differences with regard to disease characteristics in immune-mediated inflammatory diseases, including psoriasis, in immune response and susceptibility to viral infections. We performed a post hoc analysis of the Observational Study of infectious events in psoriasis complicated by active psoriatic arthritis (SYNERGY) study in patients with psoriatic arthritis (PsA) treated with immunosuppressive regimens including cyclosporine, in order to evalu...
4 CitationsSource
#1Delia ColomboH-Index: 16
#2Gilberto BelliaH-Index: 9
Last. Sara RizzoliH-Index: 2
view all 6 authors...
2 CitationsSource
#1Anthony Bewley (QMUL: Queen Mary University of London)H-Index: 19
#1A. Bewley (QMUL: Queen Mary University of London)H-Index: 8
Last. C. Ward (Mater Dei Hospital)H-Index: 1
view all 5 authors...
Background Psoriasis has a serious impact on patients' lives. However, adherence to medications is often poor, potentially compounding the burden of disease. Identifying patients who need support with psychosocial problems, or issues with adherence, can be complex. Objectives We aimed to develop statements that could assist the consultation process, identifying the relative importance of factors related to effective management of psoriasis for patients. Methods A two-stage study design was used ...
55 CitationsSource
#1Tomasz Hawro (Charité)H-Index: 21
#2Marcus Maurer (Charité)H-Index: 83
Last. Anna Zalewska (Medical University of Łódź)H-Index: 10
view all 7 authors...
Psychological resources such as hope have been suggested to positively influence quality of life (QoL) in chronic disorders. Here, we determined hope levels of psoriasis vulgaris in-patients and analyzed their relation to QoL. A total of 60 (29 male) patients were assessed for their QoL with a generic tool (WHOQOL-BREF) and a skin disease-specific instrument, the Dermatology Life Quality Index (DLQI). Hope levels were determined by use of the Basic Hope Inventory. We found a positive correlation...
24 CitationsSource
#1Delia ColomboH-Index: 1
#2Renata PeregoH-Index: 1
Psoriasis has a profound impact on patients’ everyday life. The burden of the disease ex‐ tends beyond physical manifestations and includes significant physical, social and psycho‐ logical impairment. Numerous studies have demonstrated the significant negative impact of psoriasis on quality of life (QoL) [1-5]. Furthermore, as a chronic disease, psoriasis affects the QoL of both patients and their close relatives in a cumulative way [6]. The family mem‐ bers of patients with psoriasis experience...
5 CitationsSource
#1Delia ColomboH-Index: 1
#2Antonino Di PietroH-Index: 1
Cyclosporin was isolated in 1970, by Jean Francois Borel at Sandoz Laboratories (Basel, Switzerland), from the soil fungus Tolypocladium inflatum (Borel et al., 1995; Amor et al., 2010). The compound was initially identified as a possible antifungal agent, but it was subsequently shown to have limited antifungal activity. However, in 1976, the drug demonstrated potent immunosuppressive properties, and two years later, it was successfully shown to prevent renal allograft rejection in renal transp...
3 CitationsSource
#1Sébastien Montel (Metz)H-Index: 5
#2L. AlbertiniH-Index: 1
Last. Elisabeth Spitz (Metz)H-Index: 15
view all 3 authors...
Montel S, Albertini L, Spitz E. Coping strategies as related to medical and demographic data in amyotrophic lateral sclerosis. Acta Neurol Scand: 2012: 125: 135–141. © 2011 John Wiley & Sons A/S. Introduction – The aim of this study was to examine the coping strategies of 49 patients with amyotrophic lateral sclerosis (ALS) and their relationships with medical and demographic data. Methods – A total of 49 subjects were asked to fill out a document that would provide their demographic and medical...
15 CitationsSource